Jagsonpal Pharmaceuticals Limited — Dividend/Bonus, 23-10-2024: Stock split

Jagsonpal Pharmaceuticals Limited's Board approved the unaudited financial results for Q2 and the first half of FY 2024, reflecting substantial growth. The company plans a share split, reducing face value from Rs. 5 to Rs. 2, pending shareholder approval. This aims to enhance share liquidity and attract small investors. Additionally, the company disclosed a final dividend of Rs. 5 per share and reported progress on a recent business acquisition in dermatology and childcare products.